• Cultural Enterprise & the Arts
  • Creative Enterprise & Design
  • Cultural Enterprise & the Arts
  • Creative Enterprise & Design
CATALYST | Creative Enterprise Leadership logo
  • JOIN US
    • About Our Network
    • Pratt ACM | DM Programs
    • Community News
    • Stay Connected
  • CATALYST REVIEW
  • CASES
    • Making the Case
    • Case Studies
  • CONVERSATIONS
    • Conversations of Consequence
  • CATALYST JOURNEYS
  • COLLABORATIONS
    • Capstone Projects
  • JOIN US
    • About Our Network
    • Pratt ACM | DM Programs
    • Community News
    • Stay Connected
  • CATALYST REVIEW
  • CASES
    • Making the Case
    • Case Studies
  • CONVERSATIONS
    • Conversations of Consequence
  • CATALYST JOURNEYS
  • COLLABORATIONS
    • Capstone Projects

What brand is your disease?

Tweet

What brand is your disease?

By Haris Silic
Issue 6 Winter 2010

More and more, going for a doctor’s visit resembles going to a department store. The doctors are very busy and have very little time for you, but they will do their best to be nice. You tell him or her what is ailing you, and they come back with a beautifully packaged box of samples, of medicines that is. Pills of all colors, shapes and sizes. You leave thinking, “I can’t wait to showcase my new disorder!”

This may seem exaggerated, but after reading How to brand a disease — and sell a cure, I am afraid this example is not far from reality. According to Dr. Carl Elliott, Bioethics Professor at the University of Minnesota, pharmaceutical companies have created conditions (diseases) where their drugs can literally sell themselves. They have borrowed this philosophy of creating desire for a product from Godfather of public relations Edward Bernays. In the 1920s, Bernays had to sell pianos. He was very successful at this because he sold the idea that affluent homes needed to have a music room. Once they had a music room built in their house, they would naturally buy a piano for it. It worked like magic – he designed an environment of desire where the product sold itself.

Dr. Carl Elliott argues that pharmaceutical companies take quite rare and maybe benign conditions and brand them into diseases. He lists two sorts of conditions as excellent candidates: “shameful condition that can be destigmatized” such as overactive bladder and “under-diagnosed” conditions such as “social anxiety disorder.” He concludes that branding diseases would not be so bad (after all everything else around us is branded) if it wasn’t for harmful side effects of these drugs. This is what really caught my attention.

What role do we as designers, and brand managers play in this process?
What would happen if one of our clients was part of Big Pharma, and asked us to create a brand for a drug that we knew had detrimental side effects? What would you do?

TagsBrandingDesigndiseaseethicsFeaturedPractice

Tweet
Previous Story

Making Green from Green: Get the Green Job You Want

Next Story

How Would You Redesign Today’s Cities to be More Benign?

About the author

Haris Silic

Related Posts

  • A Conversation with Ben Cameron, Jerome Foundation President on Innovation and the Audience

    By CATALYST
    Innovation and the Audience Jerome...
  • Educating for a Creative Era

    By CATALYST
    Educating for a Creative Era By David E....
  • Infographic: Mapping how the Creative Economy Contributes to the US GDP

    By CATALYST
    Mapping how the Creative Economy...
logo
  • Cultural Enterprise & the Arts
  • Creative Enterprise & Design
Copyright 2021 | Catalyst | Creative Enterprise Leadership